These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


439 related items for PubMed ID: 9316212

  • 1. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM, Anderson S.
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [Abstract] [Full Text] [Related]

  • 2. Role of local and systemic angiotensin in diabetic renal disease.
    Anderson S.
    Kidney Int Suppl; 1997 Dec; 63():S107-10. PubMed ID: 9407435
    [Abstract] [Full Text] [Related]

  • 3. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat.
    Anderson S.
    Miner Electrolyte Metab; 1998 Dec; 24(6):406-11. PubMed ID: 9930380
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [Abstract] [Full Text] [Related]

  • 5. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 6. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV, Shankland SJ.
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [Abstract] [Full Text] [Related]

  • 7. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
    Huang Q, Guo Y, Zeng H, Xie W, Yan H, Ding H.
    Endocr Res; 2011 Apr; 36(3):93-100. PubMed ID: 21314328
    [Abstract] [Full Text] [Related]

  • 8. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S.
    Scand J Urol Nephrol Suppl; 1990 Apr; 126():1-51. PubMed ID: 2194280
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    Singh R, Singh AK, Leehey DJ.
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 14. Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
    García VM, Monasterolo LA, Elías MM.
    Acta Diabetol; 2003 Sep; 40(3):130-6. PubMed ID: 14605969
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD.
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [Abstract] [Full Text] [Related]

  • 19. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
    Ibrahim HN, Rosenberg ME, Hostetter TH.
    Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.